Patients with ARMS are noted to express fusion proteins arising from the fusion of the FOXO transcription factor gene with either PAX3 (55%) or PAX7 (23%) transcription factors [14,15]. This evidence concerns the gene PAX3 and alveolar rhabdomyosarcoma.